Skip to main content

Table 1 Patient characteristics and treatments

From: Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system

 

n

Adenocarcinoma

SCC

Patients

283

  

Age (years)

 Median

78 (range 52–90)

79 (52–89)

77.5 (52–90)

Gender

 Male

214

124

74

 Female

69

61

6

Performance status

 0

58

40

13

 1

184

124

51

 2

37

19

14

 3

3

1

2

 Unknown

1

1

0

Observation period (months)

 Median

28 (range 0–127)

30 (0–127)

25 (2–101)

Institutions

 A

155

97

45

 B

67

47

16

 C

41

25

14

 D

23

16

5

Maximum tumor diameter (mm)

 Median

24 (range 9–65)

23 (9–65)

26 (13–65)

Number of tumors

 1

280

-

-

 2

3

-

-

T stage

 1a and 1b

195

131

51

 2a and 2b

91

54

29

Tumor location

 Right Upper Lobe

74

54

15

 Right Middle Lobe

18

10

7

 Right Lower Lobe

69

45

21

 Left Upper Lobe

75

47

24

 Left Lower Lobe

50

29

13

Operability

 Operable

71

49

16

 Inoperable

190

120

55

 Unknown

25

16

9

  1. SCC squamous cell carcinoma
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us